ClinConnect ClinConnect Logo
Search / Trial NCT05149976

Establishment of Voice Analysis Cohort for Development of Monitoring Technology for Dysphagia

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Nov 25, 2021

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a new way to monitor swallowing difficulties, known as dysphagia, by analyzing patients' voices. Researchers are collecting basic data to develop a technique that uses voice analysis to understand the condition better. The goal is to create a technology that could help track the state of dysphagia in patients over time.

To be eligible for this trial, participants must have dysphagia and be scheduled for a specific type of swallowing test called VFSS. They should be able to record their voice by making sounds like "Ah" or "Um." The study also welcomes healthy individuals without swallowing issues to participate, as their voices will be compared to those of patients with dysphagia. Participants can expect to provide voice recordings and undergo some assessments, but they do not need to worry if they cannot speak or follow the instructions given by the researchers, as those individuals will not be included in the study. This trial is currently recruiting participants of all ages and genders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with dysphagia and scheduled for VFSS testing
  • Patients who can record voice such as "Ah for 5 seconds", "Ah. ah. ah", or "Um\~\~"
  • Normal people (without dysphagia symptoms) who can record voice (additionally recruited for comparison of voice indicators with patients with dysphagia)
  • Exclusion Criteria:
  • Patients who cannot speak.
  • Patients who cannot speak according to the researcher's instructions.
  • Patients whose VFSS test was reexamined

About Seoul National University Hospital

Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.

Locations

Seongnam Si, Gyeonggi Do, Korea, Republic Of

Patients applied

0 patients applied

Trial Officials

Juseok Ryu, M.D. PhD

Study Director

Seoul National University Bundang Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials